Company intelligence / Profile preview
Vitanova Biomedical
Kerrville, Texas, United States
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Vitanova Biomedical is developing a nanoparticle-based, light-activated intracellular acidosis cancer therapy platform that has shown preclinical proof-of-concept for selective destruction of cancer cells with preservation of healthy tissue; there are no disclosed clinical trials yet.[1][8][10]
- Therapeutic areas
- Oncology
- Modalities
- DeviceNanoparticle
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
LiteCure Medical Lasers
Beyond the preview
Go deeper on Vitanova Biomedical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Vitanova Biomedical.